ASGR1 targeted siRNA (Front Pharma)

N/A

Report date: 2026/04/28 20:00:22
NME

Base Information

Drug NameASGR1 targeted siRNA (Front Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionAsialoglycoprotein receptor 1 inhibitors
TargetsAsialoglycoprotein receptor 1
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Front Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Front Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A